United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
608.49
+7.17 (1.19%)
Nov 4, 2026, 4:00 PM EST - Market closed
United Therapeutics Market Cap
United Therapeutics has a market cap or net worth of $26.1 billion as of November 4, 2026. It is the 951st most valuable company in the world and the 405th biggest in the United States. Its market cap has increased by 38.18% in one year.
Market Cap
26.10B
Enterprise Value
22.56B
1-Year Change
38.18%
Global Rank
Country Rank
#405 United States
Category
ChartMarket Cap Chart
Since June 17, 1999, United Therapeutics's market cap has increased from $185.60M to $26.10B, an increase of 13,961.72%. That is a compound annual growth rate of 19.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 26.10B | 24.40% |
| Dec 31, 2025 | 20.98B | 33.18% |
| Dec 31, 2024 | 15.75B | 52.44% |
| Dec 29, 2023 | 10.33B | -18.47% |
| Dec 30, 2022 | 12.67B | 30.24% |
| Dec 31, 2021 | 9.73B | 44.26% |
| Dec 31, 2020 | 6.75B | 74.53% |
| Dec 31, 2019 | 3.87B | -18.57% |
| Dec 31, 2018 | 4.75B | -25.75% |
| Dec 29, 2017 | 6.39B | 5.09% |
| Dec 30, 2016 | 6.08B | -14.87% |
| Dec 31, 2015 | 7.15B | 16.16% |
| Dec 31, 2014 | 6.15B | 8.32% |
| Dec 31, 2013 | 5.68B | 109.29% |
| Dec 31, 2012 | 2.71B | -1.54% |
| Dec 30, 2011 | 2.76B | -23.40% |
| Dec 31, 2010 | 3.60B | 26.94% |
| Dec 31, 2009 | 2.83B | 95.09% |
| Dec 31, 2008 | 1.45B | -30.01% |
| Dec 31, 2007 | 2.08B | 64.45% |
| Dec 29, 2006 | 1.26B | -20.99% |
| Dec 30, 2005 | 1.60B | 58.72% |
| Dec 31, 2004 | 1.01B | 105.98% |
| Dec 31, 2003 | 488.70M | 39.91% |
| Dec 31, 2002 | 349.30M | 65.94% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 66.42B |
| Teva Pharmaceutical Industries | 48.83B |
| Haleon | 40.04B |
| Zoetis | 36.86B |
| Viatris | 22.08B |
| Neurocrine Biosciences | 16.81B |
| Elanco Animal Health | 12.65B |
| Dr. Reddy's Laboratories | 12.09B |